A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...
September 7, 2023—(BRONX, NY)—In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center...
Guitarists will do just about anything to get just the right sound out of their setup, including purposely introducing all manner of distortion into...
ARTICLE | RegulationPlus: Atreca scraps lead program, turns to ADCs and updates from ALX Oncology, Hansoh-Antengene, Foghorn, Galera, Cascade By BioCentury Staff
August 12, 2023...